Moloney Securities Asset Management, LLC Precision Biosciences Inc Transaction History

Moloney Securities Asset Management, LLC

$706 Million
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$0.29 - $0.45 $72,137 - $111,937	248,750 Added 38.78%	890,250 $320,000
Q3 2023 Oct 31, 2023	BUY	$0.34 - $0.69 $112,030 - $227,354	329,500 Added 105.61%	641,500 $218,000
Q2 2023 Jul 31, 2023	SELL	$0.52 - $0.91 $108,680 - $190,190	-209,000 Reduced 40.12%	312,000 $165,000
Q1 2023 May 12, 2023	SELL	$0.7 - $1.41 $46,550 - $93,765	-66,500 Reduced 11.32%	521,000 $390,000
Q4 2022 Jan 30, 2023	SELL	$0.97 - $45.0 $43,650 - $2.03 Million	-45,000 Reduced 7.11%	587,500 $699,000
Q3 2022 Oct 31, 2022	BUY	$1.22 - $40.8 $113,826 - $3.81 Million	93,300 Added 17.3%	632,500 $822,000
Q2 2022 Aug 03, 2022	BUY	$1.15 - $3.34 $83,950 - $243,820	73,000 Added 15.66%	539,200 $863,000
Q1 2022 May 10, 2022	BUY	$2.96 - $7.76 $293,099 - $768,395	99,020 Added 26.97%	466,200 $1.44 Million
Q4 2021 Jan 28, 2022	SELL	$7.4 - $11.66 $58,793 - $92,638	-7,945 Reduced 2.12%	367,180 $2.72 Million
Q3 2021 Oct 27, 2021	BUY	$9.18 - $14.15 $119,340 - $183,950	13,000 Added 3.59%	375,125 $4.33 Million
Q2 2021 Jul 26, 2021	SELL	$8.07 - $12.52 $413,991 - $642,276	-51,300 Reduced 12.41%	362,125 $4.53 Million
Q1 2021 Apr 28, 2021	BUY	$8.57 - $15.79 $612,112 - $1.13 Million	71,425 Added 20.88%	413,425 $4.28 Million
Q4 2020 Feb 08, 2021	BUY	$5.98 - $12.47 $606,970 - $1.27 Million	101,500 Added 42.2%	342,000 $2.85 Million
Q3 2020 Oct 20, 2020	BUY	$4.65 - $8.73 $390,483 - $733,101	83,975 Added 53.65%	240,500 $1.48 Million
Q2 2020 Jul 31, 2020	BUY	$4.66 - $8.7 $207,486 - $387,367	44,525 Added 39.75%	156,525 $1.3 Million
Q1 2020 May 08, 2020	BUY	$5.05 - $15.01 $418,392 - $1.24 Million	82,850 Added 284.22%	112,000 $675,000
Q4 2019 Feb 06, 2020	BUY	$6.32 - $19.66 $184,228 - $573,089	29,150 New	29,150 $405,000

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $584M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.

Account